| S-Biomedic N.V.. (7/2/20). "Press Release: S-Biomedic Is Gearing Up for Significant Growth and Has Appointed a New CCO". Beerse. |
2020-07-02 |
| Immatics N.V.. (7/2/20). "Press Release: Immatics Announces Completion of Business Combination and Listing on NASDAQ". Houston, TX & Tübingen. |
2020-07-02 |
| Cergentis B.V.. (6/29/20). "Press Release: Cergentis Appoints New CEO and Board Members". Utrecht. |
2020-06-29 |
| Scenic Biotech B.V.. (6/23/20). "Press Release: Scenic Biotech Awarded €3.1 Million Innovation Credit from Dutch Government to Progress CD47/QPCTL Immuno-oncology Program". Amsterdam. |
2020-06-23 |
| Hyloris Pharmaceuticals S.A.. (6/17/20). "Press Release: Hyloris Pharmaceuticals Launches Its Initial Public Offering on Euronext Brussels [Not for US, AU, CA, CH, IL, JP or ZA]". Liège. |
2020-06-17 |
| Biognosys AG. (6/17/20). "Press Release: Biognosys Announces Appointment of Dr. Patrick Vink as Chairman". Schlieren. |
2020-06-17 |
| Ona Therapeutics. (6/16/20). "Press Release: Ona Therapeutics Raises €30m in Series A Financing". Barcelona. |
2020-06-16 |
| eTheRNA Immunotherapeutics N.V.. (6/16/20). "Press Release: eTheRNA Raises EUR 34 Million in Series B Financing to Accelerate Multiple mRNA Therapeutic Development Programs Through to Clinical Proof of Concept". Niel. |
2020-06-16 |
| Bavarian Nordic A/S. (6/12/20). "Press Release: Bavarian Nordic to Manufacture Additional Ebola Vaccines for Janssen". Copenhagen. |
2020-06-12 |
| Affimed N.V.. (6/11/20). "Press Release: Affimed Announces Appointment of Angus Smith as Chief Financial Officer". Heidelberg. |
2020-06-11 |
| Oncoinvent AS. (6/11/20). "Press Release: Oncoinvent Announces Dosing of First Patient with Radspherin in a Second Phase 1 Clinical Trial". Oslo. |
2020-06-11 |
| Bioqube Ventures. (6/10/20). "Press Release: Bioqube Ventures Launches Bioqube Factory Fund I". Hasselt/Brussels. |
2020-06-10 |
| iTeos Therapeutics Inc.. (6/9/20). "Press Release: iTeos Therapeutics Strengthens Leadership Team. Matthew Gall Joins as Chief Financial Officer". Cambridge, MA & Gosselies. |
2020-06-09 |
| Boehringer Ingelheim. (6/8/20). "Press Release: New Consortium EUbOPEN Will Provide Tools to Unlock Disease Biology. 66 Million Euros to Generate Open-access Chemical Tools". Frankfurt & Ingelheim. |
2020-06-08 |
| Hyloris Pharmaceuticals S.A.. (6/3/20). "Press Release: Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussels [Not for US, AU, CA, CH, IL, JP or ZA]". Liège. |
2020-06-03 |
| Prilenia Therapeutics B.V.. (6/3/20). "Press Release: Prilenia Therapeutics Raises $62.5m to Fund Late Stage Trials in HD and ALS". Naarden & Herzliya. |
2020-06-03 |
| Argenx SE. (5/29/20). "Press Release: Argenx Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs". Breda & Ghent. |
2020-05-29 |
| Miltenyi Biotec B.V. & Co. KG. (5/28/20). "Press Release: Miltenyi Biotec Launches World’s First Fully Automated Light Sheet Microscope". Bergisch Gladbach. |
2020-05-28 |
| Argenx SE. (5/28/20). "Press Release: Argenx Raises $750 Million in Gross Proceeds in a Global Offering". Breda & Ghent. |
2020-05-28 |
| High-Tech Gründerfonds Management GmbH. (5/27/20). "Press Release: Kumovis Closes Series A Funding Led by Renolit and Solvay". |
2020-05-27 |
| Argenx SE. (5/26/20). "Press Release: Argenx Announces Launch of Proposed Global Offering". Breda & Ghent. |
2020-05-26 |
| Argenx SE. (5/26/20). "Press Release: Argenx Announces Positive Topline Phase 3 ADAPT Trial Results". Breda & Ghent. |
2020-05-26 |
| Hyloris Pharmaceuticals S.A.. (5/26/20). "Press Release: Hyloris Appoints Patrick Jeanmart as Chief Financial Officer". Liège. |
2020-05-26 |
| Syngulon S.A.. (5/16/20). "Press Release: Enzymicals and Syngulon Sign a Non-exclusive License Agreement on the Use of Syngulon’s Antibiotic Free Technology to Produce Enzymes". Seraing. |
2020-05-16 |
| Lava Therapeutics B.V.. (5/15/20). "Press Release: Lava Therapeutics Announces Collaboration with Janssen to Develop Bi-specific Gamma-Delta T-cell Engager Therapeutics". Utrecht. |
2020-05-15 |
| Polyganics B.V.. (5/13/20). "Press Release: Polyganics Awarded €1.2 Million for Clinical Development of Liver and Pancreas Sealant Patch". Groningen. |
2020-05-13 |
| Innovative Medicines Initiative (IMI). (5/12/20). "Press Release: IMI Announces COVID Projects, Boosts Funding Pot to EUR 72 million". Brussels. |
2020-05-12 |
| [iito] Business Intelligence. (5/4/20). "Press Release: [iito] Brings Back the Past into the [LSE] Newsletter". Bremen. |
2020-05-04 |
| Hyloris Pharmaceuticals S.A.. (4/30/20). "Press Release: Hyloris Pharmaceuticals Successfully Raises €15 Million in Funding Round". Liège. |
2020-04-30 |
| Kurma Partners. (4/29/20). "Press Release: Kurma Partners Announces the Final Closing of Its Kurma Biofund III Fund at €160 Million". Paris. |
2020-04-29 |
| Bone Therapeutics S.A.. (4/29/20). "Press Release: Bone Therapeutics Secures EUR 11.0 Million Financing". Gosselies. |
2020-04-29 |
| Genedata AG. (4/28/20). "Press Release: Genedata Partners with Cergentis to Provide End-to-end Solution for Automating TLA-based Clone Selection". Basel. |
2020-04-28 |
| FoRx Therapeutics AG. (4/22/20). "Press Release: FoRx Therapeutics AG Raises EUR 10 Million Seed Round". Basel. |
2020-04-22 |
| Centogene B.V.. (4/17/20). "Press Release: Centogene and Ubirch Create Secure Blockchain Solution for the Successful Fight Against COVID-19". Rostock & Cologne. |
2020-04-17 |
| Eurofins Scientific. (4/16/20). "Press Release: Eurofins Genomics Launches »SARS-CoV-2 Full-length Genome Sequencing« Service to Support Researchers Globally in Their Fight against the COVID-19 Pandemic and Outbreak Source Tracing". Ebersberg. |
2020-04-16 |
| Galapagos N.V.. (4/16/20). "Press Release: Galapagos and Ryvu Announce Research Collaboration". Mechelen & Krakow. |
2020-04-16 |
| Centogene B.V.. (4/15/20). "Press Release: Centogene Announces Opening of Laboratory in Hamburg, Germany". Cambridge, MA, Rostock & Berlin. |
2020-04-15 |
| Halix B.V.. (4/15/20). "Press Release: Halix Enters Collaboration with the University of Oxford for GMP Manufacturing of a COVID-19 Vaccine". Leiden. |
2020-04-15 |
| GlaxoSmithKline plc. (4/14/20). "Press Release: Sanofi and GSK to Join Forces in Unprecedented Vaccine Collaboration to Fight COVID-19". London. |
2020-04-14 |
| Gadeta B.V.. (4/7/20). "Press Release: Gadeta Appoints Marco Londei as Chief Executive Officer". Utrecht. |
2020-04-07 |
| iTeos Therapeutics Inc.. (4/1/20). "Press Release: iTeos Therapeutics Closes $125 Million Series B2 Financing". Cambridge, MA & Gosselies. |
2020-04-01 |
| Gilde Healthcare Partners. (3/31/20). "Press Release: Gilde Healthcare Raises €416 million ($450 million) Venture and Growth Capital Fund". Utrecht & Cambridge, MA. |
2020-03-31 |
| InflaRx N.V.. (3/31/20). "Press Release: InflaRx Doses First Patient in Multicenter Randomized Clinical Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRx’s anti-C5a Technology". Jena. |
2020-03-31 |
| AM-Pharma B.V.. (3/31/20). "Press Release: AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI". Utrecht. |
2020-03-31 |
| Qiagen N.V.. (3/31/20). "Press Release: Qiagen Receives U.S. FDA EUA for QIAstat-Dx Test Kit, First and Only Syndromic Solution Integrating Detection of SARS-CoV-2 Coronavirus". Germantown, MD & Hilden. |
2020-03-31 |
| Medigene AG. (3/26/20). "Press Release: Medigene Provides Results for Fiscal Year 2019 and Outlook". Martinsried. |
2020-03-26 |
| Bone Therapeutics S.A.. (3/26/20). "Press Release: Bone Therapeutics Appoints Stefanos Theoharis as Chief Business Officer". Gosselies. |
2020-03-26 |
| Qiagen N.V.. (3/24/20). "Press Release: Qiagen Names Thierry Bernard as Chief Executive Officer". Venlo, Hilden & Germantown, MD. |
2020-03-24 |
| Immatics Biotechnologies GmbH. (3/17/20). "Press Release: Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies". Houston, TX & Tübingen. |
2020-03-17 |
| Affimed N.V.. (3/17/20). "Press Release: Affimed Announces Appointment of Arndt Schottelius, M.D. Ph.D. as Chief Scientific Officer". Heidelberg. |
2020-03-17 |
| Life Sciences Partners (LSP). (3/10/20). "Press Release: LSP Closes Largest Ever European Life Sciences Fund at $600 Million". Amsterdam, Munich & Boston, MA. |
2020-03-10 |
| UCB S.A.. (3/9/20). "Press Release: UCB Announces Appointment of Sandrine Dufour as New Chief Financial Officer". Brussels. |
2020-03-09 |
| Orionis Biosciences. (3/5/20). "Press Release: Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets". Boston, MA & Ghent. |
2020-03-05 |
| Biocartis Group N.V.. (3/5/20). "Press Release: Biocartis Announces New Immuno-Oncology Project with Bristol-Myers Squibb Aimed at Registration of Idylla MSI test in China". Mechelen. |
2020-03-05 |
| Biocartis Group N.V.. (3/5/20). "Press Release: Biocartis Announces 2019 Results and 2020 Outlook". Mechelen. |
2020-03-05 |
| Biotalys N.V.. (3/5/20). "Press Release: Biotalys Announces Second Closing of €45 Million Series C Financing Round". Ghent. |
2020-03-05 |
| Qiagen N.V.. (3/3/20). "Press Release: Thermo Fisher Scientific to Acquire Qiagen N.V.". Waltham, MA & Venlo. |
2020-03-03 |
| Qiagen N.V.. (3/3/20). "Press Release: Conclusion of a Business Combination Agreement between Qiagen N.V. and Thermo Fisher Scientific Inc., Announcement of a Public Tender Offer by Thermo Fisher Scientific Inc. [Ad hoc]". Venlo. |
2020-03-03 |
| Uniqure N.V.. (3/2/20). "Press Release: Uniqure and Gen-X Enter into Research Collaboration and License Agreement for the Development of Novel Synthetic Promoters". Lexington, MA & Amsterdam. |
2020-03-02 |
| Uniqure N.V.. (3/2/20). "Press Release: Uniqure Announces 2019 Financial Results and Highlights Recent Company Progress". Lexington, MA & Amsterdam. |
2020-03-02 |
| PDC*line Pharma S.A.. (3/2/20). "Press Release: PDC*line Pharma Announces the Administration of a First Patient with Its Therapeutic Cancer Vaccine Candidate (PDC*lung01) Targeting Non-small Cell Lung Cancer". Liège & Grenoble. |
2020-03-02 |
| iTeos Therapeutics S.A.. (2/27/20). "Press Release: iTeos Therapeutics Initiates Phase 1/2 Study with Highly Innovative Anti-TIGIT Antibody in Patients with Advanced Cancers". Cambridge, MA & Gosselies. |
2020-02-27 |
| Genedata AG. (2/26/20). "Press Release: Leading Biopharma Experts Drive R&D Innovation and Process Efficiency at the Genedata Partner Symposium". Basel. |
2020-02-26 |
| DSM N.V.. (2/21/20). "Press Release: DSM to Acquire Glycom to Accelerate Growth in Early Life Nutrition". Heerlen. |
2020-02-21 |
| Adrenomed AG. (2/21/20). "Press Release: Adrenomed Announces Positive Top-Line AdrenOSS-2 Phase II Results with Adrecizumab in Septic Shock". Hennigsdorf. |
2020-02-21 |
| Univercells S.A.. (2/18/20). "Press Release: Univercells Secures up to €50M Investment from KKR Platform to Speed Delivery of Manufacturing Technologies". Brussels. |
2020-02-18 |
| OncoDNA S.A.. (2/14/20). "Press Release: OncoDNA Closes Successful Series B Investment Round". Gosselies. |
2020-02-14 |
| Azafaros B.V.. (2/6/20). "Press Release: Azafaros Completes EUR 25 Million Series A Financing to Advance Rare Metabolic Disorders Pipeline". Leiden. |
2020-02-06 |
| Gilead Sciences, Inc.. (2/4/20). "Press Release: Gilead Sciences Announces Fourth Quarter and Full Year 2019 Financial Results". Foster City, CA. |
2020-02-04 |
| Catalent, Inc.. (2/3/20). "Press Release: Catalent, Inc. Announces Pricing of Public Offering of Common Stock". Somers, NJ. |
2020-02-03 |
| Qiagen N.V.. (2/3/20). "Press Release: Qiagen Launches FFPE and Liquid Biopsy PIK3CA Diagnostics in Europe to Enhance Precision Medicine in Advanced Breast Cancer". Germantown, MD & Hilden. |
2020-02-03 |
| Catalent, Inc.. (2/3/20). "Press Release: Catalent to Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform". Somers, NJ & Gosselies. |
2020-02-03 |
| iTeos Therapeutics S.A.. (1/30/20). "Press Release: iTeos Therapeutics Awarded €15 Million in Non-Dilutive Funding by the Walloon Region". Gosselies & Cambridge, MA. |
2020-01-30 |
| Biocartis Group N.V.. (1/27/20). "Press Release: Biocartis Announces Resignation of CFO". Mechelen. |
2020-01-27 |
| C4Diagnostics S.A.S.. (1/24/20). "Press Release: C4Diagnostics Raises € 2.3 Million in Series A and Brings a US Investor to the Founding Round, to Accelerate the Deployment of Its Infectious Diseases’ Diagnostic Solutions". |
2020-01-24 |
| Galapagos N.V.. (1/23/20). "Press Release: Galapagos Appoints Michele Manto as Chief Commercial Officer". Mechelen. |
2020-01-23 |
| iOnctura B.V.. (1/23/20). "Press Release: iOnctura Raises EUR 15 Million in Series A Financing to Progress Its Pipeline into Clinical Development". Amsterdam. |
2020-01-23 |
| PDC*line Pharma S.A.. (1/22/20). "Press Release: PDC*line Pharma Raises €20 million in Series B Financing Round". Liège & Grenoble. |
2020-01-22 |
| BlueRock Therapeutics. (1/21/20). "Press Release: Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes". Leiden & Cambridge, MA. |
2020-01-21 |
| Osteolabs GmbH. (1/20/20). "Press Release: Osteolabs GmbH Successfully Closes First International Commercial Agreements and Starts Contract Research Collaboration with the Health Department of an European Army". Kiel. |
2020-01-20 |
| Qiagen N.V.. (1/16/20). "Press Release: Qiagen Launches Oncology Molecular Profiling Services in Europe. Qiagen Clinical Insights (QCI) Fully Integrates N-of-One Product into Portfolio". Redwood City, CA & Hilden. |
2020-01-16 |
| Galapagos N.V.. (1/15/20). "Press Release: Fibrocor and Galapagos Sign Expanded Collaboration in Fibrosis". Mechelen & Toronto. |
2020-01-15 |
| Vivoryon Therapeutics AG. (1/14/20). "Press Release: Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration". Halle (Saale) & Herlev. |
2020-01-14 |
| Curetis N.V.. (1/14/20). "Press Release: Curetis Launches Unyvero LRT Panel for BAL Specimens in the U.S.". Amsterdam, Holzgerlingen & San Diego, CA. |
2020-01-14 |
| ProBioGen AG. (1/14/20). "Press Release: ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement for Novel Bispecific Molecule". Berlin & Utrecht. |
2020-01-14 |
| Qiagen N.V.. (1/13/20). "Press Release: Qiagen Builds on Global Collaboration with Amgen for Companion Diagnostic Development in Non-small Cell Lung Cancer". Hilden & Germantown, MD. |
2020-01-13 |
| Galapagos N.V.. (1/13/20). "Press Release: Galapagos Completes Recruitment of PINTA Trial in Idiopathic Pulmonary Fibrosis". Mechelen. |
2020-01-13 |
| Qiagen N.V.. (1/10/20). "Press Release: Qiagen Celebrates Surpassing 2,500 Cumulative Placements of QIAsymphony. Milestone Instrument Placed with Cenata GmbH in Germany". Hilden & Germantown, MD. |
2020-01-10 |
| NBE Therapeutics AG. (1/10/20). "Press Release: NBE-Therapeutics Closes a USD 22M Series C Financing Round". Basel. |
2020-01-10 |
| Wellington Partners. (1/8/20). "Press Release: Karl Naegler Joins Wellington Partners as Managing Partner". Munich. |
2020-01-08 |
| NorthSea Therapeutics B.V.. (1/8/20). "Press Release: NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA Study in NASH and to Advance Two Additional SEFAs into the Clinic". Naarden. |
2020-01-08 |
| CureVac AG. (1/7/20). "Press Release: CureVac Announces Positive Results in Low Dose – 1 µg – Rabies Vaccine Clinical Phase 1 Study". Tübingen & Boston, MA. |
2020-01-07 |
| Galecto Biotech AB. (1/7/20). "Press Release: Galecto and PharmAkea Merge to Create Strong Clinical-stage Company Developing First-in-Class Therapeutics in Fibrosis and Cancer". San Diego, CA & Copenhagen. |
2020-01-07 |
| Bone Therapeutics S.A.. (12/19/19). "Press Release: Bone Therapeutics Announces the Appointment of Dr. Miguel Forte as CEO to Lead the Company into the Next Phase of Development". Gosselies. |
2019-12-19 |
| BioNTech SE. (12/17/19). "Press Release: European Investment Bank Provides Funding of €50 Million to BioNTech as Part of the Investment Plan for Europe". Luxembourg & Mainz. |
2019-12-17 |
| Cellestia Biotech AG. (12/17/19). "Press Release: Successful Closing of Series B Financing Round with CHF 20M". Basel. |
2019-12-17 |
| Augustine Therapeutics. (12/16/19). "Press Release: VIB and KU Leuven Announce New Spin-off Augustine Therapeutics to Fight Neuromuscular Diseases". Belgium. |
2019-12-16 |
| Promethera Biosciences S.A.. (12/16/19). "Press Release: Promethera Attracts Sony Innovation Fund by IGV and Pegasus Tech Ventures as New Investors in Final Closing of Series D . Total Amount Raise in the Series D Reaches €47.2 Million". Mont-Saint-Guibe |
2019-12-16 |
| SphingoTec GmbH. (12/16/19). "Press Release: SphingoTec’s Proprietary Biomarker bio-ADM Detects Residual Congestion in Patients with Heart Failure". Hennigsdorf. |
2019-12-16 |
| iTeos Therapeutics S.A.. (12/12/19). "Press Release: iTeos Therapeutics Announces Collaboration with Merck Investigating the Combination of its A2A Antagonist with Keytruda". Gosselies & Cambridge, MA. |
2019-12-12 |
![[LSBNL] Life-Sciences-Benelux.com - The Benelux Life Sciences Web Portal](/images/basics/lsbnl-life-sciences-benelux-portal-logo-2019.png){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
